/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/4252x1496/43d16b540f/ehra-acronym-name-rgb.png)
Prolonged intensified medical treatment to improve left ventricular function in newly diagnosed heart failure: the HF-OPT study
Event: Heart Failure 2024
Topic: Heart Failure and Left Ventricular Dysfunction
Session: Guideline recommended medical therapy and sudden cardiac death risk management of patients with new presentation of heart failure reduced ejection fraction
When to implant an ICD in patients with heart failure and reduced ejection fraction? Insights from the HF-OPT trial.
Event: EHRA 2024
Topic: Device Treatment
Session: Ventricular tachycardia 4
Effective patient management and protection from sudden cardiac death in the high-risk phase in patients with newly diagnosed heart failure
Event: Heart Failure 2023
Topic: Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
Session: Effective patient management and protection from sudden cardiac death in the high-risk phase in patients with newly diagnosed heart failure
Wide complex tachycardia - Rare, but curable
Event: EHRA 2023
Topic: Electrocardiography (ECG)
Session: EHRA Tracing - ECG - Day 3
Distilling the clinical evidence behind the WCD - What have clinical trials and registries told us?
Event: Heart Failure 2019
Topic: Treatment
Session: Who should receive the wearable cardioverter defibrillator? Evidence and risk stratification for prevention of sudden cardiac death
Wearable cardioverter defibrillator - Programming and troubleshooting
Event: EHRA 2019
Topic: Implantable Cardioverter-Defibrillator (ICD)
Session: Mastering ICD therapy
Improving outcomes for newly diagnosed heart failure patients
Event: ESC Congress 2018
Topic: Prevention
Session: Applying the wearable cardioverter defibrillator in clinical practice
WEARIT-II Europe: data from a German multi-center prospective registry.
Event: EHRA 2018
Topic: Ventricular Arrhythmias and SCD - Prevention
Session: Proven protection from sudden cardiac death – The wearable cardioverter defibrillator
Screening: an efficient way to identify your patient at risk for sudden cardiac death.
Event: ESC Congress 2017
Topic: Sudden death / resuscitation
Session: The important role of the wearable cardioverter defibrillator for acute myocardial infarction patients
Reduction of inappropriate shocks of ICDs with enhanced SVT discriminators. First results from the ReduceIT study
Event: EHRA EUROPACE - CARDIOSTIM 2017
Topic: Technical aspects (Sudden cardiac death and implantable defibrillators)
Session: Rapid Fire session 1 - ICD and prevention of sudden death
